Suboptimal glycemic control, independently of QT interval duration, is associated with increased risk of ventricular arrhythmias in a high-risk population

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 1, 2006, Pages 9-14

  Chen Scarabelli, Carol ^a   Scarabelli, Tiziano M ^b,c  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmias; Clinical electrophysiology; Drugs; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HEART VENTRICLE ARRHYTHMIA; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; IMPLANT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT; QT INTERVAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SUDDEN DEATH;

AGED; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TACHYCARDIA, VENTRICULAR;

EID: 33645127832     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00298.x     Document Type: Article

References (41)

1. National Diabetes Statistics 2002 accessed on 8/17/2004 at
2. Abraira C Duckworth W McCarren M Emanuele N Arca D Reda D Henderson W VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2 Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial J Diabetes Complications 2003 17 6 314 322
3. Sobel BE Effects of glycemic control and other determinants on vascular disease in type 2 diabetes Am J Med 2002 113 Suppl. 6A 12S 22S
4. Jaffe AS Spadaro JJ Schechtman K Roberts R Geltman EM Sobel BE Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus Am Heart J 1984 108 1 31 37
5. Harjai KJ Stone GW Boura J Mattos L Chandra H Cox D Grines L O'Neill W Grines C Primary Angioplasty in Myocardial Infarction Investigators Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction Am J Cardiol 2003 91 9 1041 1045
6. Corpus RA George PB House JA Dixon SR Ajluni SC Devlin WH Timmis GC Balasubramaniam M O'Neill WW Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention J Am Coll Cardiol 2004 43 1 8 14
7. Mathew V Gersh BJ Williams BA Laskey WK Willerson JT Tilbury RT Davis BR Holmes DR Jr. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: A report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial Circulation 2004 109 4 476 480
8. Carson JL Scholz PM Chen AY Peterson ED Gold J Schneider SH Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery J Am Coll Cardiol 2002 40 3 418 423
9. McAlister FA Man J Bistritz L Amad H Tandon P Diabetes and coronary artery bypass surgery: An examination of perioperative glycemic control and outcomes Diabetes Care 2003 26 5 1518 1524
10. Stratton IM Adler AI Neil HA Matthews DR Manley SE Cull CA Hadden D Turner RC Holman RR Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study BMJ 2000 321 7258 405 412
11. Corpus RA O'Neill WW Dixon SR Timmis GC Devlin WH Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization Am J Cardiol 2003 92 11 1282 1286
12. Lazar HL Chipkin SR Fitzgerald CA Bao Y Cabral H Apstein CS Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events Circulation 2004 109 12 1497 1502
13. Sivieri R Veglio M Chinaglia A Scaglione P Cavallo-Perin P Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes Diabet Med 1993 10 10 920 924
14. Pourmoghaddas A Hekmatnia A The relationship between QTc interval and cardiac autonomic neuropathy in diabetes mellitus Mol Cell Biochem 2003 249 1-2 125 128
15. Marfella R Rossi F Giugliano D Hyperglycemia and QT interval: Time for re-evaluation Diabetes Nutr Metab 2001 14 2 63 65
16. Veglio M Borra M Stevens LK Fuller JH Perin PC The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group Diabetologia 1999 42 1 68 75
17. Veglio M Chinaglia A Cavallo Perin P The clinical utility of QT interval assessment in diabetes Diabetes Nutr Metab 2000 13 6 356 365
18. Brown DW Giles WH Greenlund KJ Valdez R Croft JB Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey J Cardiovasc Risk 2001 8 4 227 233
19. Soman SS Sandberg KR Borzak S Hudson MP Yee J McCullough PA The independent association of renal dysfunction and arrhythmias in critically ill patients Chest 2002 122 2 669 677
20. Bakth S Arena J Lee W Torres R Haider B Patel BC Lyons MM Regan TJ Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning J Clin Invest 1986 77 2 382 395
21. Stevens MJ Raffel DM Allman KC Dayanikli F Ficaro E Sandford T Wieland DM Pfeifer MA Schwaiger M Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk Circulation 1998 98 10 961 968
22. Ziegler D Weise F Langen KJ Piolot R Boy C Hubinger A Muller-Gartner HW Gries FA Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: A 4-year prospective study in IDDM patients Diabetologia 1998 41 4 443 451
23. Scognamiglio R Negut C De Kreutzenberg SV Tiengo A Avogaro A Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients Circulation 2005 112 2 179 184
24. Srinivasan M Herrero P McGill JB Bennik J Heere B Lesniak D Davila-Roman VG Gropler RJ The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus J Am Coll Cardiol 2005 46 1 42 48
25. Johansen JS Harris AK Rychly DJ Ergul A Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice Cardiovasc Diabetol 2005 4 1 5
26. + channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms J Biol Chem 2003 278 12 10417 10426
27. Di Filippo C D'Amico M Marfella R Berrino L Giugliano D Rossi F Endothelin-1 receptor antagonists reduce cardiac electrical instability induced by high glucose in rats Naunyn Schmiedebergs Arch Pharmacol 2002 366 3 193 197
28. Giugliano D Marfella R Coppola L Verrazzo G Acampora R Giunta R Nappo F Lucarelli C D'Onofrio F Vascular effects of acute hyperglycemia in humans are reversed by l -arginine. Evidence for reduced availability of nitric oxide during hyperglycemia Circulation 1997 95 7 1783 1790
29. D'Amico M Marfella R Nappo F Di Filippo C De Angelis L Berrino L Rossi F Giugliano D High glucose induces ventricular instability and increases vasomotor tone in rats Diabetologia 2001 44 4 464 470
30. Marfella R Nappo F De Angelis L Siniscalchi M Rossi F Giugliano D The effect of acute hyperglycaemia on QTc duration in healthy man Diabetologia 2000 43 5 571 575
31. Goligorsky MS Chen J Brodsky S Workshop: Endothelial cell dysfunction leading to diabetic nephropathy: Focus on nitric oxide Hypertension 2001 37 2 Part 2 744 748
32. Marfella R Quagliaro L Nappo F Ceriello A Giugliano D Acute hyperglycemia induces an oxidative stress in healthy subjects J Clin Invest 2001 108 4 635 636
33. Brodsky SV Morrishow AM Dharia N Gross SS Goligorsky M Glucose scavenging of nitric oxide Am J Physiol Renal Physiol 2001 280 3 F480 F486
34. Weihrauch D Lohr NL Mraovic B Ludwig LM Chilian WM Pagel PS Warltier DC Kersten JR Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin Circulation 2004 109 19 2343 2348
35. Kersten JR Toller WG Tessmer JP Pagel PS Warltier DC Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism Am J Physiol Heart Circ Physiol 2001 281 5 H2097 H20104
36. Hoit BD Two faces of nitric oxide: Lessons learned from the NOS2 knockout Circ Res 2001 89 4 289 291
37. Kubota I Han X Opel DJ Zhao YY Baliga R Huang P Fishman MC Shannon RP Michel T Kelly RA Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase J Mol Cell Cardiol 2000 32 7 1239 1248
38. Kis A Vegh A Papp JG Parratt JR Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: Role of nitric oxide J Mol Cell Cardiol 1999 31 6 1229 1241
39. Fei L Baron AD Henry DP Zipes DP Intrapericardial delivery of l -arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: Nitric oxide modulates sympathetic effects on ventricular electrophysiological properties Circulation 1997 96 11 4044 4049
40. Kis A Vegh A Papp J Parratt J Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase Br J Pharmacol 1999 127 7 1545 1550
41. Mungrue IN Gros R You X Pirani A Azad A Csont T Schulz R Butany J Stewart DJ Husain M Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death J Clin Invest 2002 109 6 735 743